OrbiMed’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-250,000
Closed -$9.89M 167
2021
Q4
$9.89M Hold
250,000
0.13% 116
2021
Q3
$5.93M Hold
250,000
0.07% 148
2021
Q2
$6.14M Hold
250,000
0.06% 141
2021
Q1
$4.57M Buy
+250,000
New +$4.57M 0.04% 146